20mgPurity Exceeds 99%
GLP-3 (RT) 20mg
Retatrutide (LY3437943)
GLP-3 (RT) is a research peptide that acts as a triple agonist on GLP-1, GIP, and glucagon receptors. The 20mg variant offers increased concentration for extended research protocols.
For Research Use Only
Not for human consumption, veterinary use, or any therapeutic applications.
Purity
Purity Exceeds 99%
Storage
36-46°F (2-8°C)
Origin
Made in USA
Documentation
COA Available
Procurement Information
This product is available exclusively to qualified research institutions and licensed facilities through authorized distribution channels.
- Valid research credentials required
- Orders processed through authorized agents only
- End-user certification documentation required
Research Mechanisms
- Triple receptor agonist (GLP-1, GIP, Glucagon)
- Research into appetite regulation pathways
- Studies on insulin sensitivity mechanisms
- Investigation of metabolic rate modulation
- Exploration of lipid metabolism pathways
Research Background
- Phase 2 clinical trials published in NEJM (2023)
- TRIUMPH Phase 3 trials completed
- Significant findings in body composition research
- Studies showing up to 24% change in body weight markers
Storage & Handling
Recommended Storage Conditions
Store at 36-46°F (2-8°C). Protect from light. Do not freeze.
- - Keep away from direct sunlight
- - Maintain consistent temperature
- - Check expiration date before use
- - Reconstituted peptides: use within 28 days
